Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies.

Hanania, N. A., Yohannes, A. M., Ozol-Godfrey, A., Tocco, M., Goodin, Th., Sharma, S. & Sanjar, S. (2021).
International Journal of Chronic Obstructive Pulmonary Disease 2021:16 865–875.

To Publication


Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer.

Abd-Elaziz, K., Elberink, H. O. & Diamant, Z. (2020).
European Clinical Respiratory Journal 2020, VOL. 7, 1809083.

To Publication

Observational Real-World Study to Assess Clinical Characteristics and Device Satisfaction in Patients with COPD Treated with Glycopyrrolate/eFlow® CS.

Stephenson, J.J., Dembek, C., Caldwell-Tarr, A., Conto, R.M., Paullin, M., Kerwin, E.M. (2020).
Int J Chron Obstruct Pulmon Dis. 2020 Jul 14;15:1713-1727. eCollection 2020.

To Publication

Aerosol Pirfenidone Pharmacokinetics after Inhaled Delivery in Sheep: a Viable Approach to Treating Idiopathic Pulmonary Fibrosis.

Kaminskas, L. M., Landersdorfer, C. B., Bischof, R. J., Leong, N., Ibrahim, J., Davies, A. N., Pham, S., Beck, S., Montgomery, B., Surber, M. W. (2020).
Pharmaceutical Research volume 37, Article number: 3 (2020).

To Publication


Making Concentrated Antibody Formulations Accessible for Vibrating-Mesh Nebulization.

Beck-Broichsitter, M. (2019).
Journal of Pharmaceutical Sciences 108 (2019) 2588-2592.

To Publication

A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase 1 Study of Aerosolized Pirfenidone Delivered via the PARI Investigational eFlow Nebulizer in Volunteers and Patients with Idiopathic Pulmonary Fibrosis.

Khoo, J. K., Montgomery, A. B., Otto, K. L., Surber, M., Faggian, J., Lickliter, J. D., Glaspole, I. (2019).
Journal of aerosol medicine and pulmonary drug delivery, 32(0), 1-6.

To Publication

A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation.

Iacono, A., Wijesinha, M., Rajagopal, K., Murdock, N., Timofte, I., Griffith, B., Terrin, M. (2019).
ERJ Open Research 2019 5: 00167-2019.

To Publication

Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis.

Barth, P., Bruijnzeel, P., Wach, A., Sellier Kessler, O., Hooftman, L., Zimmermann, J., Naue, N., Huber, B., Heimbeck, I., Kappeler, D., Timmer, W., Chevalier, E. (2019).
Journal of Cystic Fibrosis.

To Publication

Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates.

Vonarburg, C., Loetscher, M., Spycher, M. O., Kropf, A., Illi, M., Salmon, S., Roberts, S., Steinfuehrer, K., Campbell, I., Koernig, S., Bain, J., Edler, M., Baumann, U., Miescher, S., Metzger, D. W., Schaub, A., Käsermann, F. & Zuercher, A. W. (2019).
Respiratory Research 2019.

To Publication


In vitro characterization of the eFlow closed system nebulizer with glycopyrrolate inhalation solution.

Pham, S., Ferguson, G. T., Kerwin, E., Goodin, T., Wheeler, A., & Bauer, A. (2018).
Journal of aerosol medicine and pulmonary drug delivery, 31(3), 162-169.

To Publication

Monitoring nebuliser usage & lung function in clinical trials.

Fuchs, C., & Koehler, Y. (2018).
ONdrugDelivery Publishing 2018, June 6th, 87, 66-70.

To Publication


Monitoring adherence to treatment regimen of inhaled medication use in a clinical trial with an investigational eFlow nebulizer (eTrack).

Fuchs, C., Brosig, M., Finke, M., Fiebig, D., Soni, P., Tutuncu, A., Saponjic, R., & Knoch, M. (2017).
European Respiratory Journal 2017, 50.

To Publication


Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients.

Sawicki, G. S., Chou, W., Raimundo, K., Trzaskoma, B., & Konstan, M. W. (2015).
Journal of Cystic Fibrosis, 14(6), 777-783.

To Publication

In-vitro Study of Aerosolised Colistin Delivered to the Nasal Tract via a Pulsating Aerosol Delivery Device (Vibrent®).

Schuschnig, U., Seidler, A., Seemann, S., & Knoch, M. (2015).
20th International Congress of the International Society for Aerosols in Medicine (ISAM), Munich, Germany, May 30 to June 3, 2015.

To Publication


Drug delivery to paranasal sinuses using pulsating aerosols.

Moeller, W., Schuschnig, U., Bartenstein, P., Meyer, G., Haeussinger, K., Schmid, O., & Becker, S. (2014).
Journal of aerosol medicine and pulmonary drug delivery, 27(4), 255-263.

To Publication

The eFlow ‘‘closed system’’(CS) - a novel device platform for liquid aerosol drug-device combinations.

Gallem, T. (2014).
ONdrugDelivery Publishing 2014, June 19th, 50,13-16 (

To Publication

A pharmacokinetics and safety comparison of a highly concentrated tobramycin solution with TOBI.

Griese, M., Eismann, C., Börner, G., Denk, O., Schierholz, J. M., Keller, M., Mazurek, H., & Kappler, M. (2014).
Journal of aerosol medicine and pulmonary drug delivery, 27(3), 185-192.

To Publication

Some cystic fibrosis patients do not tolerate tobramycin dry powder inhalation.

Boerner, G., Prante, S., & Borella, F. (2014).
Journal of Cystic Fibrosis, 13, S121.

To Publication


Topical Drug Delivery in Chronic Rhinosinusitis Patients before and after Sinus Surgery Using Pulsating Aerosols.

Möller, W., Schuschnig, U., Celik, G., Münzing, W., Bartenstein, P., Häussinger, K., Kreyling, W. G., Knoch, M., Canis, M., & Becker, S. (2013).
PloS one, 8(9), e74991.

To Publication

Pulsating Aerosols - New Therapy Options for Upper Airway Diseases.

Möller, W., Schuschnig, U., Becker, S., Saba, G. K., Münzing, W., Bartenstein, P., & Knoch, M. (2013).
Journal of aerosol medicine and pulmonary drug delivery, 26(4), 257-258.


Assessing Modeled C O 2 Retention and Rebreathing of a Facemask Designed for Efficient Delivery of Aerosols to Infants.

Mundt, C., Sventitskiy, A., Cehelsky, J. E., Patters, A. B., Tservistas, M., Hahn, M. C., Juhl, G., & DeVincenzo, J. P. (2012).
ISRN pediatrics, 2012.

To Publication


A Comparison of Amount and Speed of Deposition Between the PARI LC STAR® Jet Nebulizer and an Investigational eFlow® Nebulizer.

Coates, A. L., Green, M., Leung, K., Chan, J., Ribeiro, N., Ratjen, F., & Charron, M. (2011).
Journal of aerosol medicine and pulmonary drug delivery, 24(3), 157-163.

To Publication

Nasally inhaled pulsating aerosols: lung, sinus and nose deposition.

Moller, W., Saba, G. K., Haussinger, K., Becker, S., Keller, M., & Schuschnig, U. (2011).
Rhinology, 2011.

To Publication

Objective Evaluation Of Adherence To Inhaled Liposomal Cyclosporin Therapy For Lung Transplant Patients In A Clinical Trial.

Fuchs, C., Prante, S., Pokorski, R., Lim, H., Denk, O., Seemann, S., & Knoch, M. (2011).
Pediatric Pulmonology, 46(34), 418.

To Publication


Pulsating aerosols for drug delivery to the sinuses in healthy volunteers.

Möller, W., Schuschnig, U., Khadem Saba, G., Meyer, G., Junge-Hülsing, B., Keller, M., & Häussinger, K. (2010).
Otolaryngology - Head and Neck Surgery, 142(3), 382-388.

To Publication

Optimising drug and device together for novel aerosol therapies.

Keller, M., & Knoch, M. (2010).
ONdrugDelivery Magazine, (17), 12-16.

To Publication


Lung Deposition of a Liposomal Cyclosporine A Inhalation Solution in Patients after Lung Transplantation.

Behr, J., Zimmermann, G., Baumgartner, R., Leuchte, H., Neurohr, C., Brand, P., Herpich, C., Sommerer, K., Seitz, K., Menges, G., Tillmanns, S., Keller, M., & the Munich Lung Transplant Group (2009).
Journal of aerosol medicine and pulmonary drug delivery, 22(2), 121-130.

To Publication

A Novel Nebuliser for the Simultaneous Administration of siRNA and Supplemental Oxygen for RSV in Infants.

Tservistas, M., Hahn, M., DeVincenzo, J., Hetzer, U., Uhlig, M., Cehelsky, J., Walsh, E., Kreutzer, T., O`Connor, S., Knoch, M. (2009).
Drug Delivery to the Lungs - DDL20, Edinburgh, United Kingdom, December 9-11, 2009. Proceedings: 53-56.

To Publication


New advances in aerosolised drug delivery: vibrating membrane nebuliser technology.

Lass, J. S., Sant, A., & Knoch M. (2006).
Expert opinion on drug delivery, 3(5), 693-702.

To Publication


The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems.

Knoch, M., & Keller M. (2005).
Expert opinion on drug delivery, 2(2), 377-390.

To Publication

Contact us

Do you have any questions about our technology, partnering approach and services?

Please contact us!


I have acknowledged the information regarding data processing.